RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
18F-FDG pet does not improve contrast enhanced CT scan sensitivity in the evaluation of liver metastases after chemotherapy
2006-01-01 Carnaghi, Carlo; Chiti, Arturo; Rimassa, Lorenza; Zuradelli, Monica; Tondulli, Luca; Torzilli, G; Doci, Roberto; Tronconi Maria, Chiara; Pressiani, Tiziana; Santoro, Armando
A new human cell line, PDSS-26, from poorly differentiated synovial sarcoma, with unique chromosomal anomalies
2003-01-01 Berardi, Ac; Parafioriti, A; Barisani, D; Papp, B; Armiraglio, E; Martinoli, M; Dalpra, L; Santoro, A
A phase I clinical and pharmacokinetic study evaluating vinflumine in combination with epirubicin as first-line treatment in metastatic breast cancer
2014-01-01 Chan, S; Campone, M; Santoro, A; Conte, P F; Bostnavaron, M; Nguyen, L
A phase II randomised (calibrated design) study on the activity of the single-agent trabectedin in metastatic or locally relapsed uterine leiomyosarcoma
2018-01-01 Gadducci, A; Grosso, F; Scambia, G; Raspagliesi, F; Colombo, N; Grignani, G; Casali, P; Sanfilippo, R; Buonadonna, A; Santoro, A; Bruzzone, M; Artioli, G; Lorusso, D; Biagioli, E; Fossati, R; Galli, F; Negri, E; Rulli, E; Torri, V; D’Incalci, M
A Phase II Randomized Dose Escalation Trial of Sorafenib in Patients with Advanced Hepatocellular Carcinoma
2013-01-01 Rimassa, L; Pressiani, T; Boni, C; Carnaghi, C; Rota Caremoli, E; Fagiuoli, S; Foa, P; Salvagni, S; Cortesi, E; Tronconi, Mc; Personeni, N; Bozzarelli, S; Banzi, Mc; Fanello, S; Lutman, Fr; Giordano, L; Santoro, A
A phase II randomized multicenter trial of gefitinib plus FOLFIRI and FOLFIRI alone in patients with metastatic colorectal cancer
2008-01-01 Santoro, A; Comandone, A; Rimassa, L; Granetti, C; Lorusso, V; Oliva, C; Ronzoni, M; Siena, S; Zuradelli, M; Mari, E; Pressiani, T; Carnaghi, C
A Phase II randomized study evaluating the addition of iniparib to gemcitabine plus cisplatin as first-line therapy for metastatic non-small cell lung cancer.
2014-01-01 Novello, S; Besse, B; Felip, E; Barlesi, F; Mazieres, J; Zalcman, G; Von Pawel, J; Reck, M; Cappuzzo, F; Ferry, D; Carcereny, E; Santoro, A; Garcia-Ribas, I; Scagliotti, G; Soria, J C
A phase II study of the combination of gemcitabine and imatinib mesylate in pemetrexed-pretreated patients with malignant pleural mesothelioma
2020-01-01 Zucali, Pa; Perrino, M; de Vincenzo, F; Giordano, L; Cordua, N; D’Antonio, F; Santoro, A
A Phase-1b study of tivantinib (ARQ 197) in adult patients with hepatocellular carcinoma and cirrhosis
2013-01-01 Santoro, A; Simonelli, M; Rodriguez-Lope, C; Zucali, P; Camacho, Lh; Granito, A; Senzer, N; Rimassa, L; Abbadessa, G; Schwartz, B; Lamar, M; Savage, Re; Bruix, J
A pilot analysis of headache disorders in breast cancer patients
2021-01-01 De Sanctis, Rita; Viganò, Alessandro; Pindilli, Sebastiano; Torrisi, Rosalba; Santoro, Armando
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
18F-FDG pet does not improve contrast enhanced CT scan sensitivity in the evaluation of liver metastases after chemotherapy | 1-gen-2006 | Carnaghi, Carlo; Chiti, Arturo; Rimassa, Lorenza; Zuradelli, Monica; Tondulli, Luca; Torzilli, G; Doci, Roberto; Tronconi Maria, Chiara; Pressiani, Tiziana; Santoro, Armando | |
A new human cell line, PDSS-26, from poorly differentiated synovial sarcoma, with unique chromosomal anomalies | 1-gen-2003 | Berardi, Ac; Parafioriti, A; Barisani, D; Papp, B; Armiraglio, E; Martinoli, M; Dalpra, L; Santoro, A | |
A phase I clinical and pharmacokinetic study evaluating vinflumine in combination with epirubicin as first-line treatment in metastatic breast cancer | 1-gen-2014 | Chan, S; Campone, M; Santoro, A; Conte, P F; Bostnavaron, M; Nguyen, L | |
A phase II randomised (calibrated design) study on the activity of the single-agent trabectedin in metastatic or locally relapsed uterine leiomyosarcoma | 1-gen-2018 | Gadducci, A; Grosso, F; Scambia, G; Raspagliesi, F; Colombo, N; Grignani, G; Casali, P; Sanfilippo, R; Buonadonna, A; Santoro, A; Bruzzone, M; Artioli, G; Lorusso, D; Biagioli, E; Fossati, R; Galli, F; Negri, E; Rulli, E; Torri, V; D’Incalci, M | |
A Phase II Randomized Dose Escalation Trial of Sorafenib in Patients with Advanced Hepatocellular Carcinoma | 1-gen-2013 | Rimassa, L; Pressiani, T; Boni, C; Carnaghi, C; Rota Caremoli, E; Fagiuoli, S; Foa, P; Salvagni, S; Cortesi, E; Tronconi, Mc; Personeni, N; Bozzarelli, S; Banzi, Mc; Fanello, S; Lutman, Fr; Giordano, L; Santoro, A | |
A phase II randomized multicenter trial of gefitinib plus FOLFIRI and FOLFIRI alone in patients with metastatic colorectal cancer | 1-gen-2008 | Santoro, A; Comandone, A; Rimassa, L; Granetti, C; Lorusso, V; Oliva, C; Ronzoni, M; Siena, S; Zuradelli, M; Mari, E; Pressiani, T; Carnaghi, C | |
A Phase II randomized study evaluating the addition of iniparib to gemcitabine plus cisplatin as first-line therapy for metastatic non-small cell lung cancer. | 1-gen-2014 | Novello, S; Besse, B; Felip, E; Barlesi, F; Mazieres, J; Zalcman, G; Von Pawel, J; Reck, M; Cappuzzo, F; Ferry, D; Carcereny, E; Santoro, A; Garcia-Ribas, I; Scagliotti, G; Soria, J C | |
A phase II study of the combination of gemcitabine and imatinib mesylate in pemetrexed-pretreated patients with malignant pleural mesothelioma | 1-gen-2020 | Zucali, Pa; Perrino, M; de Vincenzo, F; Giordano, L; Cordua, N; D’Antonio, F; Santoro, A | |
A Phase-1b study of tivantinib (ARQ 197) in adult patients with hepatocellular carcinoma and cirrhosis | 1-gen-2013 | Santoro, A; Simonelli, M; Rodriguez-Lope, C; Zucali, P; Camacho, Lh; Granito, A; Senzer, N; Rimassa, L; Abbadessa, G; Schwartz, B; Lamar, M; Savage, Re; Bruix, J | |
A pilot analysis of headache disorders in breast cancer patients | 1-gen-2021 | De Sanctis, Rita; Viganò, Alessandro; Pindilli, Sebastiano; Torrisi, Rosalba; Santoro, Armando |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 1 Contributo su Rivista 730
- 1 Contributo su Rivista::1.1 Arti... 730
Data di pubblicazione
- In corso di stampa 5
- 2020 - 2024 187
- 2010 - 2019 314
- 2000 - 2009 139
- 1990 - 1999 52
- 1982 - 1989 33
Rivista
- ANNALS OF ONCOLOGY 64
- JOURNAL OF CLINICAL ONCOLOGY 50
- BONE MARROW TRANSPLANTATION 28
- EUROPEAN JOURNAL OF CANCER 21
- THE LANCET ONCOLOGY 19
- LUNG CANCER 14
- BRITISH JOURNAL OF CANCER 13
- CANCERS 13
- HAEMATOLOGICA 13
- BLOOD 12
Keyword
- Humans 27
- Female 15
- Middle Aged 13
- Male 12
- Adult 10
- Aged 10
- COVID-19 10
- breast cancer 9
- immunotherapy 8
- Hodgkin lymphoma 7
Lingua
- eng 448
- ita 2
Accesso al fulltext
- no fulltext 533
- reserved 184
- open 13